| Business

Become a contributor

Bookmark Econotimes

| Business

Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing

Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit

Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO

Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million

Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies

Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances

Washington Post Publisher Will Lewis Steps Down After Layoffs

Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning

Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate

Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal

Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil

Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains

SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off

SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates

Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports

Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch

OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering

©Econometrics LLC . All Rights Reserved.

Teligent, Inc. to Present at the Raymond James 39th Annual Institutional Investors Conference on Wednesday March 7, 2018

Monday, March 5, 2018 9:30 PM UTC

BUENA, N.J., March 05, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Raymond James 39th Annual Institutional Investors Conference. The Conference is taking place March 4-7, 2018 at the J.W. Marriott Grande Lakes, Orlando, FL.

Jason Grenfell-Gardner, President and CEO and Damian Finio, Chief Financial Officer of Teligent, Inc. will present on Wednesday March 7^th at 9:15 a.m. ET.

The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.teligent.com. A replay will be available for 30 days.

About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.

Contact:
Martin Wilson
Teligent, Inc.
856-336-9120
www.teligent.com

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Market Data

Sydney Braces for Pro-Palestine Protests During Israeli President Isaac Herzog’s Visit

Samsung Electronics Shares Jump on HBM4 Mass Production Report

China Overturns Death Sentence of Canadian Robert Schellenberg, Signaling Thaw in Canada-China Relations

Ghislaine Maxwell to Invoke Fifth Amendment at House Oversight Committee Deposition

Trump Congratulates Japan’s First Female Prime Minister Sanae Takaichi After Historic Election Victory

Trump Administration Appeals Court Order to Release Hudson Tunnel Project Funding

Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances

Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible

Japan’s Prime Minister Sanae Takaichi Secures Historic Election Win, Shaking Markets and Regional Politics

EconoTimes

Disclaimer: EconoTimes provides references and links to selected blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the blogs or other sources of information. Clients and prospects are advised to carefully consider the opinions and analysis offered in the blogs or other information sources in the context of the client or prospect's individual analysis and decision making. None of the blogs or other sources of information is to be considered as constituting a track record. Past performance is no guarantee of future results and EconoTimes specifically advises clients and prospects to carefully review all claims and representations made by advisors, bloggers, money managers and system vendors before investing any funds or opening an account with any Brokerage. Any news, opinions, research, data, or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. EconoTimes expressly disclaims any liability for any lost principal or profits without limitation which may arise directly or indirectly from the use of or reliance on such information. As with all such advisory services, past results are never a guarantee of future results.

Teligent, Inc. to Present at the Raymond James 39th Annual Institutional Investors Conference on Wednesday March 7, 2018

Editor's Picks

Welcome to EconoTimes